IMMU-16. INTRA-TUMOURAL IL-12 DELIVERY ENABLES CAR T-CELL IMMUNOTHERAPY FOR HIGH-GRADE GLIOMA

Treatment with T-cells redirected to tumour specificity with a chimeric antigen receptor (CAR) may be well suited to treat intracranial tumours due to the ability of T-cells to access the central nervous system and migrate to infiltrative sites of disease. In adult glioblastoma, a case report of loc...

Descripción completa

Detalles Bibliográficos
Autores principales: Agliardi, Giulia, Liuzzi, Anna Rita, Hotblack, Alastair, De Feo, Donatella, Núñez, Nicolás, Friebel, Ekaterina, Nannini, Francesco, Roberts, Thomas, Ramasawmy, Rajiv, Stowe, Cassandra, Williams, Iwan, Siow, Bernard, Lythgoe, Mark, Kalber, Tammy, Quezada, Sergio, Pule, Martin, Tugues, Sonia, Becher, Burkhard, Straathof, Karin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715834/
http://dx.doi.org/10.1093/neuonc/noaa222.372

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715834/
http://dx.doi.org/10.1093/neuonc/noaa222.372

Ejemplares similares